On the 19th of September, we presented the 9th webinar of our NASH Webinar Series. During this webinar, speaker Professor Zelber-Sagi explored the relationship between diet and NAFLD, emphasizing that diet not only causes NAFLD but can also serve ...
Julius Clinical’s proprietary global network dedicated to MASH (formerly known as NASH) research.
NASH Clinical comprises a global network of clinicians, investigators, and experts in the MASH field. NASH Clinical’s mission is to help decrease the problems that arise from Metabolic dysfunction-associated steatohepatitis (MASH) worldwide.
Who we are
The participating clinicians in NASH Clinical are endocrinologists, gastroenterologists, diabetologists, and general internists. They have connections with numerous hospitals worldwide. NASH Clinical’s goals are to raise awareness and share insights about this endemic disease, collaboratively create easy and accurate diagnostic tools that can be used to identify patients, and to conduct fatty liver clinical trials that could help mitigate the risks associated with this disease.
Where we come from
NASH Clinical was created by Julius Clinical in 2018. The founding members are academic researchers who were — and continue to be — connected through research, education, or other activities in this area.
With the deep experience of NASH Clinical’s sites and investigators, and the cohesion derived from lengthy relationships and fast, transparent communication, we have the tools in place to precisely determine the potential of your novel MASH (NASH) treatment.
What we do
Interdisciplinary collaboration is essential to combat MASH (NASH). The aim of this network is to work collaboratively, discover and disseminate insights, create advanced diagnostic tools, and conduct groundbreaking MASH clinical trials.
Recruitment in MASH is an especially difficult hurdle, with screening failure rates that often exceed 95%. NASH Clinical’s scientific approach and wealth of experience have helped refine our recruitment procedures to speed study startup and project timelines.
NASH Clinical team
We believe that a multidisciplinary network approach is needed to optimise MASH (NASH) clinical studies and collect meaningful data. Our team of experts are highly skilled in areas that position them to provide key perspectives on MASH research.
On May 23, we presented the webinar: Why NASH trials frequently fail and how to improve them Guest speaker: Professor Manuel Castro Cabezas Host: Professor Diederick E. Grobbee Fill in the form and watch the replay: ...
During the 5th Global NASH Congress in London, Our Chief Scientific Officer Prof. Dr. D.E. Grobbee was one of the speakers and presented: Getting GRIP on NASH; Implementation of an International Clinical Screening Program. During this presentat...
Explore our MASH (NASH) capabilities, case studies, and other resources.